Miricell supplementation and markers of healthy aging
Official title: Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy
Run by Nutraland USA, Inc. · NCT07675200 · Data updated 2026-11-12
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 70 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Nutraland USA, Inc. Industry-sponsored |
| Locations | 1 site (Canfield, Ohio) |
| Status | Recruiting |
| Started | January 9, 2026 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT07675200 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–70 in generally good health, able to commit to dietary controls and 12 weeks of daily supplementation.
✕Probably not a fit
Individuals with certain health conditions or non-compliance with dietary restrictions may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, placebo-controlled study investigates the effects of a standardized spermidine ingredient (Miricell) on autophagy biomarkers and overall healthy aging. Participants are assigned 1:1 to Miricell or placebo for 12 weeks, with four in-person visits for testing and safety monitoring. The study controls diet and lifestyle factors to minimize confounding from endogenous autophagy and polyamine intake, and includes cognitive testing, activity tracking, and blood biomarker analyses. Results will indicate whether Miricell can influence brain health, metabolic health, and visible aging signs in adults without major health issues. Safety and tolerability are assessed throughout the trial.
Why it matters
Potential benefit: If successful, Miricell could offer a dietary approach to support cellular health and aging-related biomarkers.
How similar studies have gone: Prior studies in polyamine/spermidine approaches have shown mixed but promising signals for autophagy and aging markers, making this area exploratory but plausible.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: * Provide voluntary signed and dated informed consent. * Be in fair health as determined by medical history and routine blood chemistries. * Age between the ages of 40 and 70 (inclusive). * Body weight of at least 110 pounds. * Normotensive (seated, resting systolic blood pressure \<140 mm Hg and diastolic blood pressure \< 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5-minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility. * Normal seated, resting heart rate (\<90 per minute). * Willing to duplicate their previous 24-hour diet, refrain from alcohol for 24 hours, exercise for 24 hours prior to each trial, caffeine for 12 hours prior to each trial, and fast for 10 hours prior to each of the treatments. * Participant agrees to maintain existing dietary and physical activity patterns throughout the study period. * Participant is willing and able to comply with the study protocol. * If a dietary supplement was initiated within the past month, the participant is willing to discontinue supplement use followed by a 2-week washout prior to participation in the study. * Able to provide an adequate blood draw. EXCLUSION CRITERIA: * Use of probiotics, postbiotics or antibiotics within the past month. * A history of unstable or new-onset cardiovascular/cardiorespiratory, liver, or renal disease. * The participant's alcohol consumption is more than two standard alcoholic drinks per day or more than 10 drinks per week or has a history of drug/alcohol abuse or dependence. * History of diabetes (any form) or any endocrine disorder. * Fasting blood sugar of \> 125 mg/dL. * Current smokers who smoke 11 or more cigarettes per day (i.e. light smokers will be enrolled if they meet all other criteria). * History of hyperparathyroidism or an untreated thyroid disease. * History of malignancy in the previous five years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin). * Chronic inflammatory condition or disease (e.g., rheumatoid arthritis, Crohn's Disease, ulcerative colitis, lupus, HIV/AIDS, etc.). * Previous medical diagnosis of gout or fibromyalgia. * Any female who is pregnant, trying to become pregnant, is less than/or equal to 120 days postpartum, or any current women who are nursing. * Women who participate in this study must agree to the use of contraception for the duration of the study, and any sexually active woman will have to take a negative pregnancy test prior to enrolling. Women of childbearing age (any woman prior to menopause), regardless of their use of contraception, will be provided a urine pregnancy test kit at their screening visit and take the test in private using the female lavatory after signing an informed consent. * Known allergy or sensitivity to any ingredient in the test formulations as listed on the product label. * Any other diseases or conditions that, in the opinion of the medical staff, could confound the primary endpoints or place the subject at increased risk of harm if they were to participate.
Where it's running
-
The Center for Applied Health Sciences
Canfield, Ohio, United States Recruiting
Study contacts
- Study coordinator: Michael B La Monica, Ph.D., CSCS
- Email: ML@appliedhealthsciences.org
- Phone: 330-206-0767
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
-
Hormones, Pain, and Exercise: Sports Bras for Full-Busted Women
This study tests whether specially designed sports bras can reduce neck, shoulder, arm, and back pain in full-busted women, and whether hormones, inflammation, or brain changes affect pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.